Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
Ruxolitinib | CAS 941678-49-5 | InvivoGen
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
Frontiers | JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
Understanding STAT3, the intersection of many carcinogenic signaling pathways
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
JAK/STAT signaling in hematological malignancies | Oncogene
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
JAK-STAT Signaling Pathway - YouTube
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
JAKs and STATs in Immunity, Immunodeficiency, and Cancer | NEJM
Current and future status of JAK inhibitors - The Lancet
Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors - Welsch - 2017 - European Journal of Immunology - Wiley Online Library
The role of JAK/STAT signaling pathway and its inhibitors in diseases - ScienceDirect
The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
APExBIO - JAK/STAT Signaling - Signaling Pathways
Cells | Free Full-Text | Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
The molecular details of cytokine signaling via the JAK/STAT pathway - Morris - 2018 - Protein Science - Wiley Online Library
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
JCI - JAK inhibitors in autoinflammation
